Screener
Nurix Therapeutics, Inc. NRIX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | May 31,2026 | November 30,2025 |
|---|---|---|
| Operating lease right-of-use assets | 50,107 | 50,517 |
| Property and equipment, net | 20,007 | 22,490 |
| Restricted cash | 968 | 968 |
| Other assets | 7,977 | 7,341 |
| Total assets | $535,540 | $688,135 |
| Liabilities and stockholdersʼ equity | ||
| Current liabilities: | ||
| Accounts payable | $12,208 | $11,215 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s other non-current assets?
- Nurix Therapeutics, Inc. (NRIX) reported other non-current assets of $7.98M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Nurix Therapeutics, Inc.'s other non-current assets increased by 25.9% year-over-year, from $6.34M to $7.98M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s other non-current assets has grown at a 110.6% compound annual growth rate (CAGR), from $177K to $7.34M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Nurix Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude